| Literature DB >> 30315204 |
K Cui1, B Wang1, T Ma1, B W Si1, N F Zhang1, Y Tu1, Q Y Diao2.
Abstract
The present study aimed to investigate the compensatory effect of early protein restriction followed by a realimentation on growth performance of lamb and to explore the transcriptomic changes in liver. Thirty-two lambs with an initial birth weight of 2.3 ± 0.20 kg that were weaned on day 15 were randomly divided into two groups. The lambs were fed a basal diet with normal protein level (NPL, protein level in the milk replacer and starter, 25 and 21%, respectively) or low protein level (LPL, protein level in the milk replacer and starter, 19 and 15%, respectively) from 15 to 60 d, after which all lambs consumed the same diet with a normal protein level from 61 to 90 d. Protein restriction led to a significant decrease in average daily gain (ADG), body weight and liver weight (P < 0.05). Transcriptome analysis showed that 302 or 12 differentially expressed genes (DEGs) were identified during the restriction or recovery periods, respectively (P < 0.05). The Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis indicated that DEGs enriched in nutrient metabolism and antioxidant capacity were down-regulated, while vessel development and immunity response-related genes up-regulated. The genes involved in metabolism of tyrosine were still down-regulated in the realimentation phase. Studies in this area indicated the accelerated growth effect of early protein restriction followed by a realimentation on growth performance of lambs and explored the transcriptomics change of liver which can help to develop feeding strategies to optimize the use of feedstuffs and in providing a new perspective for the study of early nutrition and epigenetics in later life.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30315204 PMCID: PMC6185953 DOI: 10.1038/s41598-018-33407-w
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Effects of protein deficiency and realimentation on growth performance of lambs.
| Items | Treatments | SEM | ||
|---|---|---|---|---|
| NPL | LPL | |||
|
| ||||
| 1d | 2.37 | 2.29 | 0.04 | 0.294 |
| 15d | 6.13 | 6.03 | 0.14 | 0.474 |
| 60d | 16.6a | 14.3b | 0.48 | 0.001 |
| 90d | 26.1a | 24.1b | 0.60 | 0.006 |
|
| ||||
| 15 to 60d | 239.7a | 189.4b | 7.51 | 0.003 |
| 61 to 90d | 320.3 | 334.3 | 8.10 | 0.449 |
| 15 to 90d | 267.2a | 241.6b | 6.65 | 0.013 |
|
| ||||
| 60d | 438.3a | 392.7b | 12.0 | 0.046 |
| 90d | 654.9a | 605.4b | 10.4 | 0.026 |
The significance was calculated using Paired T-test software (Version 9.2, SAS Institute Inc., NC, USA).
In a given row, the different small letter superscripts indicate that the difference between the two values is significant (P < 0.05).
NPL: normal protein level; LPL: low protein level.
Intake of milk replacer, starter and its major nutrients during the restriction and realimentation phases.
| Items | Groups | SEM | |||
|---|---|---|---|---|---|
| NPL | LPL | ||||
| 15–60 d | Milk replacer and its major nutrients intake/d | ||||
| Milk replacer intake (g) | 190.01 | 180.10 | 3.47 | 0.1898 | |
| CP intake (g) | 47.65a | 34.63b | 2.53 | 0.0014 | |
| GE intake (MJ) | 3.88 | 3.67 | 0.07 | 0.1724 | |
| Starter and its major nutrients intake/d | |||||
| Starter intake (g) | 332.84 | 305.91 | 17.01 | 0.0957 | |
| CP intake (g) | 70.16a | 45.95b | 5.53 | 0.0046 | |
| GE intake (MJ) | 5.82 | 5.27 | 0.30 | 0.0703 | |
| 61–90 d | Total intake (g) | 1135.13 | 1058.48 | 26.26 | 0.1116 |
| CP intake (g) | 239.29 | 223.13 | 5.53 | 0.1116 | |
| GE intake (MJ) | 19.85 | 18.51 | 0.50 | 0.1116 | |
| 15–90 d | Total intake (g) | 767.76 | 715.00 | 19.81 | 0.0749 |
| CP intake (g) | 166.40a | 137.60b | 6.48 | 0.0094 | |
| GE intake (MJ) | 29.55 | 27.45 | 0.73 | 0.0722 | |
Figure 1Gene expression in LPL and NPL groups at 60 and 90d. (A,C) Venn diagram showing genes only expressed in the LPL group (blue circle), only expressed in the NPL group (yellow circle), and common to both groups (intersection). (B,D) Different expressed genes between the LPL and NPL groups. The red points indicated significantly up-regulated expressed genes and the green points indicated significantly down-regulated expressed genes of LPL group. The blue points indicated that no significant difference of gene expression was found between the two groups.
Figure 2GO terms of different expressed genes for Biological Process, Cellular Components and Molecular Functions. Left ordinate represents the number of different expressed genes enriched in each term and the right ordinate represents the enrichment score (defined as 2Log10 P-value).
KEGG enrichment analysis of different expressed genes.
| KEGG pathway | DEGs | BGs | Corrected | KEGG ID |
|---|---|---|---|---|
|
| ||||
| Chemical carcinogenesis | 10 | 73 | 5.07E-09 | oas05204 |
| Metabolism of xenobiotics by cytochrome P450 | 9 | 62 | 1.47E-08 | oas00980 |
| Drug metabolism-cytochrome P450 | 7 | 60 | 3.65E-06 | oas00982 |
| Glutathione metabolism | 5 | 53 | 4.61E-04 | oas00480 |
| Steroid hormone biosynthesis | 5 | 66 | 9.85E-04 | oas00140 |
| Arachidonic acid metabolism | 5 | 77 | 1.63E-03 | oas00590 |
| Glycine, serine, and threonine metabolism | 4 | 42 | 1.72E-03 | oas00260 |
| Metabolic pathways | 18 | 1256 | 5.36E-03 | oas01100 |
| Nucleotide excision repair | 3 | 43 | 2.15E-02 | oas03420 |
| Ovarian steroidogenesis | 3 | 56 | 3.93E-02 | oas04913 |
|
| ||||
| Cytokine-cytokine receptor interaction | 12 | 235 | 1.14E-03 | oas04060 |
|
| ||||
| Tyrosine metabolism | 1 | 34 | 5.65E–03 | oas00350 |
DEGs: differentially expressed genes involved in the named KEGG pathway. BGs: all genes involved in the named KEGG pathway. DEG/BG: DEGs as a percentage of BGs.
Figure 3STRING analysis shows that DEGs are involved in known and predicted protein-protein interactions. STRING is used to analyse the DEGs in liver tissue between NPL60 and LPL60. Lines of different colours represent seven types of evidence used in predicting associations. Red line: fusion evidence; green line: neighbourhood evidence; blue line: co-occurrence evidence; purple line: experimental evidence; yellow line: text mining evidence; light blue line: database evidence and black line: co-expression evidence.
Figure 4Comparison of mRNA expression ratios between LPL60 and NPL60 groups for selected genes.
Ingredients and nutrient composition of the milk replacer and starter (dry matter basis).
| Items | Diet | |||
|---|---|---|---|---|
| Starter | Milk replacerb | |||
| NPL | LPL | NPL | LPL | |
|
| ||||
| Corn | 49.10 | 65.90 | — | — |
| Soybean | 28.90 | 12.10 | — | — |
| Wheat Bran | 8.00 | 8.00 | — | — |
| Alfalfa | 10.00 | 10.00 | — | — |
| Premixa | 4.00 | 4.00 | — | — |
| Total | 100.00 | 100.00 | — | — |
|
| ||||
| DM | 89.65 | 90.36 | 97.73 | 97.94 |
| CP | 21.08 | 15.02 | 25.08 | 19.23 |
| DE (MJ/kg DM) | 13.06 | 13.06 | 18.38 | 18.32 |
| EE | 1.70 | 1.70 | 11.18 | 12.98 |
| Ash | 7.40 | 6.50 | 5.29 | 4.85 |
| NDF | 15.46 | 14.79 | — | — |
| ADF | 7.84 | 7.47 | — | — |
| Ca | 0.96 | 0.98 | 1.13 | 1.09 |
| P | 0.57 | 0.51 | 0.51 | 0.48 |
aThe premix provides the following per kg of diet: Fe, 22.1 g; Mn, 9.82 g; Cu, 2.25 g; Zn, 27.0 g; Se, 0.19 g; I, 0.54 g; Co, 0.09 g; vitamin A, 3.20 g; vitamin D3, 0.80 g; vitamin E, 0.4 g.
bThe milk replacer used in this study was a patented product (application number: 02128844.5). The basic component of milk replacer include soy milk powder, milk power, whey power, gelatinized starch, CaCO3, CaHPO3, NaCl, lysine, methionine, tryptophan, threonine and other mineral and vitamin premix.
NPL, normal protein level; LPL, low protein level; DM; dry matter; CP, crude protein; DE, digestible energy; EE, ether extract; NDF, neutral detergent fiber; ADF, acid detergent fiber; Ca, calcium; P, phosphorus. –,not present or can be ignored.